Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Millennium Pharmaceuticals, Inc. (MLNM) -- Ignore unavailable to you. Want to Upgrade?

To: Miljenko Zuanic who wrote (1507)	5/13/2003 8:20:46 PM
From: Ian@SI	Read Replies (1) \| Respond to of 3044

Millennium to Webcast Conference Call on Recent FDA Approval of Velcade(TM) (bortezomib) for Injection on May 14, 2003 CAMBRIDGE, Mass., May 13 /PRNewswire-FirstCall/ --Millennium Pharmaceuticals, Inc. (Nasdaq: MLNM) will hold a live webcast of its conference call at 8:30 a.m. EDT on Wednesday, May 14, 2003. Mark Levin, chairperson and chief executive officer will host the call. He will discuss the Company's recent news regarding approval of VELCADE. The live webcast can be accessed by visiting the Investor section of the Company's website, millennium.com. Following the webcast, an archived version of the call will be available at the same address until May 16, 2003. About Millennium [snip]

To: Miljenko Zuanic who wrote (1507)	5/14/2003 2:27:45 AM
From: dalroi	Read Replies (3) \| Respond to of 3044

Yeah me too my stock will be called away he should have waited 3 more days , well anyway new wind in the fda ! perhaps we should start looking at fda postponed drugs like the one from prcs/sepr. if velcade is now approived doesnt that put mlnm in a beter bargaining positon concerning partnership or is this going to be announced before the open tomorrow cheerss S